i tend to think there will be offers made to aquire AVR inside the first 3 to 4 mths once the FDA trial is underway . Although I don’t think WP will advise shareholders to accept those offers the fact the offer is there should be reflected in the SP and MC. For the moment there are entities holding down the SP and acquiring I suppose it’s a bit of a chess game . There will be a time in the not to distant future where this will be impossible but for now it’s something we need to live with . These entities appear to be doing cross trades usually with little volume to lower the SP and keep it low . They are taking advantage on the fact some investors can’t hold forever and need to cash in some shares to survive . In the big picture if all goes to plan with AVR the SP could be 20 x or more than the current SP and whom ever is behind the SP control taking place is well aware of that fact . GLTATH
AVR Price at posting:
$23.50 Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)